Aviva has reported group operating profit of £1.07bn ($1.4bn) for the first half of 2025 (H1 2025), up 22% from £875m in the same period last year.
The company said that 66% of its operating profit came from “capital-light” businesses.
IFRS profit for the period also increased, amounting to £819m in H1 2025, compared to £654m in the prior year.
Additionally, Aviva reported improvements in both Solvency II return on equity, which is now at 16.7%, and IFRS return on equity, at 20.6%.
The insurer also declared a 10% rise in its interim dividend per share to 13.1p.
Aviva completed its acquisition of Direct Line on 1 July, but its first-half financials are not yet consolidated into Aviva’s results.
Direct Line’s performance was reported to be stable, with both motor and non-motor premiums remaining constant at £1.34bn and £500m, respectively.
Direct Line’s Net Insurance Margin showed improvement, increasing by 7.6 percentage points to 9.4%.
Sales in the insurance, wealth and retirement sector have grown by 9% to £21.5bn and General Insurance premiums have seen a 7% increase to £6.29bn.
UK and Ireland general insurance premiums increased by 9% to £4.14bn, with personal lines premiums logging 3% growth.
This growth was supported by intermediary channels including a travel partnership with Nationwide.
UK commercial lines premiums increased by 15%, attributed to pricing actions, new business and the acquisition of Probitas.
Canadian general insurance premiums grew by 4% to £2.14bn (C$4bn), with 9% growth in personal lines driven by pricing actions.
The health segment of Aviva’s business saw a 14% increase in in-force premiums, which have now reached £1bn.
Protection sales decreased by 16% following the consolidation of offerings after an acquisition from AIG.
Aviva has set its sights on reaching operating profit of £2bn by 2026 and more than £5.8bn in cumulative cash remittances between 2024 and 2026.
“Aviva operating profit surges 22% in H1 2025” was originally created and published by Life Insurance International, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.